Human Genome (HGSI) and Glaxo (GSK) Announce BLISS-52 Lupus Treatment Results
Tweet Send to a Friend
Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (NYSE: GSK) today announced the full presentation of results from BLISS-52 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
